These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7915196)

  • 21. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.
    Schneider E; Horton JK; Yang CH; Nakagawa M; Cowan KH
    Cancer Res; 1994 Jan; 54(1):152-8. PubMed ID: 7903202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel mechanism of resistance to paclitaxel (Taxol) in human K562 leukemia cells by combined selection with PSC 833.
    Jaffrézou JP; Dumontet C; Derry WB; Durán G; Chen KG; Tsuchiya E; Wilson L; Jordan MA; Sikic BI
    Oncol Res; 1995; 7(10-11):517-27. PubMed ID: 8866664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of taxotere-related drug resistance in pancreatic carcinoma.
    Liu B; Staren ED; Iwamura T; Appert HE; Howard JM
    J Surg Res; 2001 Aug; 99(2):179-86. PubMed ID: 11469885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of resistance to etoposide and teniposide in acquired resistant human colon and lung carcinoma cell lines.
    Long BH; Wang L; Lorico A; Wang RC; Brattain MG; Casazza AM
    Cancer Res; 1991 Oct; 51(19):5275-83. PubMed ID: 1717144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells.
    Meschini S; Calcabrini A; Monti E; Del Bufalo D; Stringaro A; Dolfini E; Arancia G
    Int J Cancer; 2000 Sep; 87(5):615-28. PubMed ID: 10925353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laser scanning and confocal microscopy of daunorubicin, doxorubicin, and rhodamine 123 in multidrug-resistant cells.
    Weaver JL; Pine PS; Aszalos A; Schoenlein PV; Currier SJ; Padmanabhan R; Gottesman MM
    Exp Cell Res; 1991 Oct; 196(2):323-9. PubMed ID: 1680064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Xenobiotic transport differences in mouse mesangial cell clones expressing mdr1 and mdr3.
    Ernest S; Bello-Reuss E
    Am J Physiol; 1996 Mar; 270(3 Pt 1):C910-9. PubMed ID: 8638674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P-glycoprotein binding and modulation of the multidrug-resistant phenotype by estramustine.
    Speicher LA; Barone LR; Chapman AE; Hudes GR; Laing N; Smith CD; Tew KD
    J Natl Cancer Inst; 1994 May; 86(9):688-94. PubMed ID: 7908988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progressive resistance to doxorubicin in mouse leukemia L1210 cells with multidrug resistance phenotype: reductions in drug-induced topoisomerase II-mediated DNA cleavage.
    Ganapathi R; Grabowski D; Ford J; Heiss C; Kerrigan D; Pommier Y
    Cancer Commun; 1989; 1(4):217-24. PubMed ID: 2576973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi.
    Fairchild CR; Moscow JA; O'Brien EE; Cowan KH
    Mol Pharmacol; 1990 Jun; 37(6):801-9. PubMed ID: 1972772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of silent MDR1 genes in revertant cells by fusion with multidrug-resistant cells.
    Yusa K; Tamura J; Waki A; Tsuruo T
    Biochim Biophys Acta; 1995 Nov; 1269(3):260-6. PubMed ID: 7495879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression.
    Lee JS; Scala S; Matsumoto Y; Dickstein B; Robey R; Zhan Z; Altenberg G; Bates SE
    J Cell Biochem; 1997 Jun; 65(4):513-26. PubMed ID: 9178101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance.
    Azzaria M; Schurr E; Gros P
    Mol Cell Biol; 1989 Dec; 9(12):5289-97. PubMed ID: 2573836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene.
    Choi KH; Chen CJ; Kriegler M; Roninson IB
    Cell; 1988 May; 53(4):519-29. PubMed ID: 2897240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution.
    Breuninger LM; Paul S; Gaughan K; Miki T; Chan A; Aaronson SA; Kruh GD
    Cancer Res; 1995 Nov; 55(22):5342-7. PubMed ID: 7585598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of typical multidrug resistance by cyclosporin and its non-immunosuppressive analogue SDZ PSC 833 in Chinese hamster ovary cells expressing the mdr1 phenotype.
    te Boekhorst PA; van Kapel J; Schoester M; Sonneveld P
    Cancer Chemother Pharmacol; 1992; 30(3):238-42. PubMed ID: 1352739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II.
    Cole SP; Chanda ER; Dicke FP; Gerlach JH; Mirski SE
    Cancer Res; 1991 Jul; 51(13):3345-52. PubMed ID: 1675932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidrug resistance-associated protein-mediated multidrug resistance modulated by cyclosporin A in a human bladder cancer cell line.
    Kim WJ; Kakehi Y; Hirai M; Arao S; Hiai H; Fukumoto M; Yoshida O
    Jpn J Cancer Res; 1995 Oct; 86(10):969-77. PubMed ID: 7493917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells.
    Traunecker HC; Stevens MC; Kerr DJ; Ferry DR
    Br J Cancer; 1999 Nov; 81(6):942-51. PubMed ID: 10576649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.